LMR Partners’s Alignment Healthcare ALHC Stock Holding History

LMR Partners’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100,000	Closed	-$2.19M	–	1101
2021 Q1	$2.19M	Buy	+100,000	New	+$1.95M	0.05%	312

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

LMR Partners's ALHC Position: Q2 2021 in Review

LMR Partners sold out of Alignment Healthcare (ALHC) in Q2 2021, closing a stake of 100,000 shares — an estimated $2.19M sold.

LMR Partners first reported a position in ALHC in Q1 2021 and held it in 1 quarter. The position peaked at $2.19M in Q1 2021. 56 funds tracked by Wall St. Rank hold ALHC as of Q2 2021.

LMR Partners reported no remaining Alignment Healthcare position as of Q2 2021 after selling out during the quarter.
LMR Partners sold 100,000 Alignment Healthcare shares in Q2 2021, an estimated $2.19M.
LMR Partners first reported a position in Alignment Healthcare in Q1 2021 and held it in 1 quarter.
LMR Partners's Alignment Healthcare position peaked at $2.19M in Q1 2021.
56 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.